Autoantibodies in the diagnosis of systemicrheumatic diseases (Q34299389)

1 August 2017

1 reference

title

Autoantibodies in the diagnosis of systemic rheumatic diseases (English)

1 reference

1 August 2017

Autoantibodies in the diagnosis of systemicrheumatic diseases (English)

1 reference

https://api.crossref.org/works/10.1016/S0049-0172(95)80004-2

9 June 2024

1 reference

C. A. von Mühlen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7604300

9 June 2024

E. M. Tan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7604300

9 June 2024

language of work or name

1 reference

1 April 1995

1 reference

full work available at URL

1 August 2017

https://api.elsevier.com/content/article/PII:S0049017295800042?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0049-0172(95)80004-2

https://api.elsevier.com/content/article/PII:S0049017295800042?httpAccept=text/plain

9 June 2024

1 reference

https://api.crossref.org/works/10.1016/S0049-0172(95)80004-2

Seminars in Arthritis and Rheumatism

9 June 2024

published in

1 reference

1 August 2017

24

1 reference

1 August 2017

5

1 reference

1 August 2017

323-358

1 reference

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Antibodies to native DNA and serum complement (C3) levels. Application to diagnosis and classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Autoantibody to U3 Nucleolar Ribonucleoprotein (Fibrillarin) In Patients with Systemic Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Autoantibodies in scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Monoclonal autoantibody from a (New Zealand black x New Zealand white)F1 mouse and some human scleroderma sera target an Mr 34,000 nucleolar protein of the U3 RNP particle

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Autoantibody reactive with RNA polymerase III in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Autoantibodies in pathology and cell biology

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Autoantibodies as probes in cell and molecular biology

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

A small nuclear ribonucleoprotein is required for splicing of adenoviral early RNA sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Interactions between autoimmunity and molecular and cell biology. Bridges between clinical and basic sciences

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Fluorescent antibody studies with agents of varicella and herpes zoster propagated in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Anticytoskeletal autoantibodies in the connective tissue diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Clinical manifestations in patients with autoantibodies specific for nuclear lamin proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Antinuclear autoantibodies specific for lamins. Characterization and clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Autoantibodies to lamins A and C in sera of patients showing peripheral fluorescent antinuclear antibody pattern on HEP-2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Antibodies to nuclear lamin proteins in liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Autoantibodies from patients with primary biliary cirrhosis recognize a restricted region within the cytoplasmic tail of nuclear pore membrane glycoprotein Gp210

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

PBC 95k, a 95-kilodalton nuclear autoantigen in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Anti-cytoplasmic factors in the sera of patients with systemic lupus erythematosus and certain other diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Antibodies to vimentin intermediate filaments in sera from patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Hybridoma lupus autoantibodies can bind major cytoskeletal filaments in the absence of DNA-binding activity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Antineurofilament antibody evaluation in neuropsychiatric systemic lupus erythematosus. Combination with anticardiolipin antibody assay and magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Association of dry eyes and dry mouth with anti-Ro/SS-A and anti-La/SS-B autoantibodies in normal adults

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Anticentromere antibodies in subjects with no apparent connective tissue disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Naturally occurring human IgG antibodies to intracellular and cytoskeletal components of human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Antinuclear, anticytoplasmic, and anti-Sjogren's syndrome antigen A (SS-A/Ro) antibodies in female blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Detection of antibodies to DNA: a technical assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Assessment of lupus: where are we now?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Immunological studies concerning the nephritis of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Antibody recognition of Z-DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Cell biology of the snRNP particles

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Biochemical Mechanisms of Constitutive and Regulated Pre-mRNA Splicing

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Enzyme-linked immunosorbent assay using isolated (U) small nuclear ribonucleoprotein polypeptides as antigens to investigate the clinical significance of autoantibodies to these polypeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

B-cell epitopes of Sm autoantigens

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Autoantigenic epitopes of the B polypeptide of Sm small nuclear RNP particles. Identification of regions accessible only within the U1 small nuclear RNP

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Mapping of the immunoreactive domains of a small nuclear ribonucleoprotein-associated Sm-D autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Molecular cloning of a cDNA encoding the human Sm-D autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Clinical, serologic, and immunogenetic studies in childhood-onset systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Contrasting molecular patterns of MHC class II alleles associated with the anti-Sm and anti-RNP precipitin autoantibodies in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Associations between systemic lupus erythematosus and the major histocompatibility complex: clinical and immunological considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Mapping of epitopes recognized by anti-(U1)RNP autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Clinical characteristics of patients with rheumatic disorders who possess antibodies against ribonucleoprotein particles

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Clinical manifestations and anti-(U1)snRNP antibodies: a prospective study of 29 anti-RNP antibody positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Clinical associations of antiribonucleoprotein antibodies in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Undifferentiated connective tissue syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Mixed connective tissue disease, overlap syndromes, and eosinophilic fasciitis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Mixed connective tissue disease--a farewell?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

UCTD or U1 RNP-associated connective tissue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

U1-70-kd autoantibody-positive mixed connective tissue disease in children. A longitudinal clinical and serologic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Molecular genetic analysis of HLA-DR and HLA-DQ genes among anti-U1-70-kd autoantibody positive connective tissue disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

HLA-DR4 and Gm(1,3;5,21) are associated with U1-nRNP antibody positive connective tissue disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

HLA-DR antigens in systemic lupus erythematosus: association with specificity of autoantibody responses to nuclear antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Human autoantibodies against the 70-kd polypeptide of U1 small nuclear RNP are associated with HLA-DR4 among connective tissue disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Relationship of autoantibody expression and HLA phenotype in Japanese patients with connective tissue diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

IgG and IgM anti-snRNP reactivity in sequentially obtained serum samples from patients with connective tissue diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

B-cell epitopes of RNA autoantigens

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Overlapping syndromes, undifferentiated connective tissue disease, and other fibrosing conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Anti-(U1) small nuclear RNA antibodies in anti-small nuclear ribonucleoprotein sera from patients with connective tissue diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Pulmonary function in systemic lupus erythematosus is related to distinct clinical, serologic, and nailfold capillary patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Changes in anti-U1 RNA antibody levels correlate with disease activity in patients with systemic lupus erythematosus overlap syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

A 52-kD protein is a novel component of the SS-A/Ro antigenic particle

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Structure and function of La and Ro RNPs

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Function of the mammalian La protein: evidence for its action in transcription termination by RNA polymerase III

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Rheumatic disease syndromes associated with antibodies to the Ro (SS-A) ribonuclear protein

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Isolation and characterization of a cDNA clone encoding the 60-kD component of the human SS-A/Ro ribonucleoprotein autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Molecular analysis of the 60-kDa human Ro ribonucleoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Molecular definition and sequence motifs of the 52-kD component of human SS-A/Ro autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

B-cell epitopes of La and Ro autoantigens

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Sjögren's syndrome nuclear antigen B (La): cDNA cloning, structural domains, and autoepitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

The molecular basis of the SSA/Ro antigens and the clinical significance of their autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Maternal autoantibodies and pregnancy--II: The neonatal lupus syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Isolated congenital heart block. Long-term outcome of mothers and characterization of the immune response to SS-A/Ro and to SS-B/La

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

The importance of tissue substrate in the SS-A/Ro antigen-antibody system

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

B-cell epitopes of autoantigenic DNA-binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

The reaction of the lupus erythematosus (L.E.) cell factor with deoxyribonucleoprotein of the cell nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

An Immunologic Precipitin System between Soluble Nucleoprotein and Serum Antibody in Systemic Lupus Erythematosus*

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Affinity between the lupus erythematosus serum factor and cell nuclei and nucleoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Association between Lupus Psychosis and Antiribosomal P Protein Antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Central nervous system involvement in systemic lupus erythematosus. Are we any further forward?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Autoantibodies in central nervous system lupus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Anti-P antibodies are associated with psychiatric and focal cerebral disorders in patients with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Cognitive impairment and autoantibodies in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Antimyosin antibodies in CNS-lupus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Antiribosomal P protein antibodies in different populations of patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Antiribosomal P protein antibodies in systemic lupus erythematosus. A reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Characterization of proliferating cell nuclear antigen recognized by autoantibodies in lupus sera

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxiliary protein

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Anti-"dividing cell antigen" autoantibody: a novel antinuclear antibody pattern related to histones in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

NuMA protein is a human autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Psychiatric disorders in patients with systemic lupus erythematosus: lack of association with antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Antiphospholipid antibody syndrome: immunologic and clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

The role of autoantibodies in autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Antiphospholipid antibodies in systemic lupus erythematosus: clinical and laboratory associations in 111 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Thrombosis, abortion, cerebral disease, and the lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Chorea in systemic lupus erythematosus and "lupus-like" disease: association with antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Use of monoclonal antibodies for the characterization of novel DNA-binding proteins recognized by human autoimmune sera

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Nucleotide sequence and genomic structure analyses of the p70 subunit of the human Ku autoantigen: evidence for a family of genes encoding Ku (p70)-related polypeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Autoantibodies in patients with primary pulmonary hypertension: association with anti-Ku

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Properties of active nucleosomes as revealed by HMG 14 and 17 chromatography.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Autoantibodies to HMG-17 nucleosomal protein in autoimmune rheumatic diseases. Correlation with systemic lupus erythematosus clinical activity and with antibodies to double-stranded DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Autoantibodies to nonhistone chromosomal proteins HMG-1 and HMG-2 in sera of patients with juvenile rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Autoantibodies to nucleosomal proteins: antibodies to HMG-17 in autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Antibodies from patients with rheumatoid arthritis and systemic lupus erythematosus recognize different epitopes of a single heterogeneous nuclear RNP core protein. Possible role of cross-reacting antikeratin antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Antibodies from patients and mice with autoimmune diseases react with recombinant hnRNP core protein A1

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Detection and quantification of anti-Ki antibodies by enzyme-linked immunosorbent assay using recombinant Ki antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Purification and characterization of Ki antigen and detection of anti-Ki antibody by enzyme-linked immunosorbent assay in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

The SL autoantibody-antigen system: clinical and biochemical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Functional organization of the nuclear envelope

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Identification and characterization of autoantibodies against the nuclear envelope lamin B receptor from patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Autoimmune response directed against conserved determinants of nuclear envelope proteins in a patient with linear scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Autoantibodies to the heat-shock protein hsp90 in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Antiribosomal S10 antibodies in humans and MRL/lpr mice with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Circulating antibodies to prothymosin alpha in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Centromere autoantigens are associated with the nucleolus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Antinuclear antibodies in localized scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

A clinical and immunologic evaluation of women with silicone breast implants and symptoms of rheumatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Autoimmunity and selected environmental factors of disease induction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Silicone breast prostheses and rheumatic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Antinuclear autoantibodies in women with silicone breast implants

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Silicone breast implants. History, safety, and potential complications

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Antihistone antibodies in patients with localized scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

1 reference

7 January 2021

Scl 70 antibody--a specific marker of systemic sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

A recombinant topoisomerase I ELISA: screening for IgG, IgM and IgA anti-topo I autoantibodies in human sera

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Racial differences in antinuclear antibody patterns and clinical manifestations of scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Scl-86, a marker antigen for diffuse scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

A long-term longitudinal isotypic study of anti-topoisomerase I autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Anti-Scl-70 antibodies detected by immunoblotting in progressive systemic sclerosis: specificity and clinical correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Association of anti‐topoisomerase I with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Clinical associations of anticentromere antibodies and antibodies to topoisomerase I. A study of 355 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Scl 70 autoantibodies from scleroderma patients recognize a 95 kDa protein identified as DNA topoisomerase I

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Topoisomerase I identified by scleroderma 70 antisera: enrichment of topoisomerase I at the centromere in mouse mitotic cells before anaphase

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Analysis of an immunodominant epitope of topoisomerase I in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Autoantibody to centromere (kinetochore) in scleroderma sera

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Patients with anticentromere antibodies, clinical features, diagnoses and evolution

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

The CREST syndrome: a distinct serologic entity with anticentromere antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

The analysis of antinuclear and antinucleolar autoantibodies of scleroderma by radioimmunoprecipitation assays

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

THE CLINICAL ASSESSMENT OF THE SCLERODERMA SPECTRUM DISORDERS

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Anticentromere antibody in patients without CREST and scleroderma: association with active digital vasculitis, rheumatic and connective tissue disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

B-cell epitopes of scleroderma-specific autoantigens

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Identification of a subset of patients with scleroderma with severe pulmonary and vascular disease by the presence of autoantibodies to centromere and histone

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Racial differences in the frequencies of scleroderma-related autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Demographic differences in the frequencies of scleroderma-related autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Antinuclear antibody with distinct specificity for polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Cloning of a complementary DNA coding for the 100-kD antigenic protein of the PM-Scl autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Cloning and characterization of the cDNA coding for a polymyositis-scleroderma overlap syndrome-related nucleolar 100-kD protein

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Molecular characterization of an autoantigen of PM-Scl in the polymyositis/scleroderma overlap syndrome: a unique and complete human cDNA encoding an apparent 75-kD acidic protein of the nucleolar complex

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Immunogenetic associations of scleroderma-related antinuclear antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Molecular genetics of systemic sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

A Cutaneous Lesion Associated with Myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Nuclear bodies (NBs): a newly "rediscovered" organelle

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Fibrillarin: a new protein of the nucleolus identified by autoimmune sera

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Clinical association of autoantibodies to fibrillarin with diffuse scleroderma and disseminated telangiectasia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Autoantibodies in viral hepatitis-related hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Antibodies from patients with connective tissue diseases bind specific subsets of cellular RNA-protein particles

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Autoantibody to th ribonucleoprotein (nucleolar 7–2 rna protein particle) in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Immunolocalization of 7-2-ribonucleoprotein in the granular component of the nucleolus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Identification of autoantibodies to RNA polymerase II. Occurrence in systemic sclerosis and association with autoantibodies to RNA polymerases I and III

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Human autoantibody to RNA polymerase I transcription factor hUBF. Molecular identity of nucleolus organizer region autoantigen NOR-90 and ribosomal RNA transcription upstream binding factor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Autoantibodies to mitochondria in systemic sclerosis. Frequency and characterization using recombinant cloned autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Immunocytochemical characterization of human NOR-90 (upstream binding factor) and associated antigens reactive with autoimmune sera. Two MR forms of NOR-90/hUBF autoantigens

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Antimitochondrial antibodies in primary biliary cirrhosis and other disorders: definition and clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Multiplicity of antibodies in myositis sera

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis, and related disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Rat liver histidyl-tRNA synthetase. Purification and inhibition by the myositis-specific anti-Jo-1 autoantibody

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

An enzyme-linked immunosorbent assay for the detection and quantitation of anti-Jo-1 antibody in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

The role of autoantigens in the induction and maintenance of autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Lymphocyte activation markers in idiopathic myositis: changes with disease activity and differences among clinical and autoantibody subgroups

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

D-penicillamine and polymyositis: the significance of the anti-Jo-1 antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Antibody to signal recognition particle in polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Human autoantibodies reactive with the signal-recognition particle

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

A novel antibody which precipitates 7.5S RNA is isolated from a patient with autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Mechanism of protein translocation across the endoplasmic reticulum membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Topology of signal recognition particle receptor in endoplasmic reticulum membrane.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

The signal sequence of nascent preprolactin interacts with the 54K polypeptide of the signal recognition particle

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Anti-KJ: a new antibody associated with the syndrome of polymyositis and interstitial lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

The association between Mi-2 antibodies and dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Description of a serological reaction characteristic of polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Antibodies to cellular antigens in Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Serum antibody in rheumatoid arthritis reactive with a cell-associated antigen. Demonstration by precipitation and immunofluorescence

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Resolution of the identity of certain antigen-antibody systems in systemic lupus erythematosus and sjögren's syndrome: An interlaboratory collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Relationship between autoantibodies and clinical parameters in Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Serological and immunogenetic markers of extraglandular primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

HLA DR alloantigens in different subsets of patients with Sjögren's syndrome and in family members

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Sjöugren's syndrome influence of multiple hla-d region alloantigens on clinical and serologic expression

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Human autoantibody to a novel protein of the nuclear coiled body: immunological characterization and cDNA cloning of p80-coilin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Association between the nucleolus and the coiled body

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Immunological and ultrastructural studies of the nuclear coiled body with autoimmune antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Molecular biology of autoantigens and new insights into autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Antinuclear antibodies (ANAs): diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

The role of the major histocompatibility complex in autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

The molecular biology of autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Positive selection of lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Negative selection of lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Detection of anti-Ro(SSA) antibodies in autoimmune diseases: comparison of five methods

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Antinuclear antibodies in routine analysis: the relevance of putative clinical associations

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Antihistone antibodies in systemic sclerosis. Association with pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Structural features of the HMG chromosomal proteins and their genes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Two mammalian heat shock proteins, HSP90 and HSP100, are actin-binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Autoantibodies associated with lupus induced by diverse drugs target a similar epitope in the (H2A-H2B)-DNA complex

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Anti-proteinase 3 antibodies, their characterization and disease associations

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Antibodies to glycyl-transfer RNA synthetase in patients with myositis and interstitial lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Autoantibodies against a nuclear 56 kDa protein: a marker for inflammatory muscle disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Autoantibodies to the cytoskeleton in human sera

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Molecular analysis of anti-DNA antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2895%2980004-2

7 January 2021

Culture characteristics of four permanent lines of human cancer cells

19

1 reference

https://api.crossref.org/works/10.1016/S0049-0172(95)80004-2

Autoantibodies to nuclear lamins and to intermediate filament proteins: natural, pathologic or pathogenic?

9 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/S0049-0172(95)80004-2

Antibodies to cytoplasmic intermediate filaments in rheumatic diseases

9 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/S0049-0172(95)80004-2

Anti-dsDNA antibodies in laboratory workers handling blood from patients with systemic lupus erythematosus

9 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/S0049-0172(95)80004-2

Update on autoantibodies to intracellular antigens in systemic rheumatic diseases

9 June 2024

45

1 reference

https://api.crossref.org/works/10.1016/S0049-0172(95)80004-2

Antinuclear antibodies heralding the onset of systemic lupus erythematosus

9 June 2024

46

1 reference

https://api.crossref.org/works/10.1016/S0049-0172(95)80004-2

Shifts of anti-Sm-specific antibodies in patients with systemic lupus erythematosus: Analysis by counter-immunoelectrophoresis, immunoblotting and RNA-immunoprecipitation

9 June 2024

65

1 reference

https://api.crossref.org/works/10.1016/S0049-0172(95)80004-2

Serial estimation of anti-RNP antibody titers in systemic lupus erythematosus, mixed connective tissue disease and rheumatoid arthritis

9 June 2024

94

1 reference

https://api.crossref.org/works/10.1016/S0049-0172(95)80004-2

Independent expression of autoantibodies in systemic lupus erythematosus

9 June 2024

96

1 reference

https://api.crossref.org/works/10.1016/S0049-0172(95)80004-2

Characterization by human autoantibody of a nuclear antigen related to the cell cycle

9 June 2024

143

1 reference

https://api.crossref.org/works/10.1016/S0049-0172(95)80004-2

Anticardiolipin antibodies in systemic lupus erythematosus: clinical correlates, HLA associations, and impact on survival

9 June 2024

146

1 reference

https://api.crossref.org/works/10.1016/S0049-0172(95)80004-2

Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients

9 June 2024

160

1 reference

https://api.crossref.org/works/10.1016/S0049-0172(95)80004-2

Antibodies against Ku protein in sera from patients with autoimmune diseases

9 June 2024

163

1 reference

https://api.crossref.org/works/10.1016/S0049-0172(95)80004-2

Antibodies to hn-RNP protein A1 in systemic lupus erythematosus: clinical association with Raynaud's phenomenon and esophageal dysmotility

9 June 2024

172

1 reference

https://api.crossref.org/works/10.1016/S0049-0172(95)80004-2

Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease

9 June 2024

218

1 reference

https://api.crossref.org/works/10.1016/S0049-0172(95)80004-2

The heterogeneity of anticentromere antibodies in immunoblotting analysis

9 June 2024

221

1 reference

https://api.crossref.org/works/10.1016/S0049-0172(95)80004-2

Nucleolar antigens and autoantibodies in hepatocellular carcinoma and other malignancies

9 June 2024

241

1 reference

https://api.crossref.org/works/10.1016/S0049-0172(95)80004-2

Reactivity of anti-mitochondrial antibodies in primary biliary cirrhosis and systemic sclerosis

9 June 2024

256

1 reference

https://api.crossref.org/works/10.1016/S0049-0172(95)80004-2

Linked sets of antinuclear antibodies: what do they mean?

9 June 2024

291

1 reference

https://api.crossref.org/works/10.1016/S0049-0172(95)80004-2

antiphospholipid antibodies

9 June 2024

317

1 reference

https://api.crossref.org/works/10.1016/S0049-0172(95)80004-2

A novel autoantibody reactive with a 48 kDa tRNA associated protein in patients with scleroderma

9 June 2024

323

1 reference

https://api.crossref.org/works/10.1016/S0049-0172(95)80004-2

9 June 2024

Identifiers

1 reference

1 August 2017

1 reference